Amanta Healthcare Limited — Investor Meet, 08-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Amanta Healthcare held a Q1 FY27 earnings conference call discussing its financial performance and future outlook. Revenue grew 5% YoY to INR69 crore, with a stable EBITDA margin of 22%. The company is expanding its SteriPort capacity to 12 crore bottles per year, expected to start contributing significantly from Q3 FY27. The small volume SVP facility is anticipated to commence operations by Q4 FY27, targeting export markets. A 10.8 MW captive solar power project is operational, aimed at reducing costs and improving margins. Management expressed confidence in long-term value creation driven by manufacturing enhancements and product portfolio growth.